Current treatment preferences in acute myeloid leukemia: a survey in Brazil

INTRODUCTION: : Most adults with acute myeloid leukemia (AML) will eventually relapse from their disease. The combination of 7-day cytarabine and an anthracycline on days 1–3 (the so called “7 + 3” regimen) can be considered standard of care of younger patients with AML. However, the treatment of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Portugal, Rodrigo Doyle, Nucci, Márcio Luiz Moore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417458/
https://www.ncbi.nlm.nih.gov/pubmed/31780390
http://dx.doi.org/10.1016/j.htct.2019.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417458/
https://www.ncbi.nlm.nih.gov/pubmed/31780390
http://dx.doi.org/10.1016/j.htct.2019.07.005

Ejemplares similares